155 related articles for article (PubMed ID: 34820906)
1. Treatment and outcomes of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy.
Loftus JP; Miller AJ; Center SA; Peters-Kennedy J; Astor M
J Vet Intern Med; 2022 Jan; 36(1):106-115. PubMed ID: 34820906
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and amino acid profiles of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy.
Loftus JP; Center SA; Astor M; Miller AJ; Peters-Kennedy J
J Vet Intern Med; 2022 Jan; 36(1):97-105. PubMed ID: 34477245
[TBL] [Abstract][Full Text] [Related]
3. Untargeted metabolomic profiles reveal widespread metabolic perturbations and identify candidate biomarkers in aminoaciduric canine hypoaminoacidemic hepatopathy syndrome.
Loftus JP; Rubio MED; Yant J; Bichoupan A; Zhang S; Miller AJ; Center SA; Ruiz MDR; Macho LP
Am J Vet Res; 2023 Dec; 84(12):. PubMed ID: 37871610
[TBL] [Abstract][Full Text] [Related]
4. Approach to the Diagnosis of Hepatocutaneous Syndrome in Dogs: A Retrospective Study and Literature Review.
DeMarle KB; Webster CRL; Penninck D; Ferrer L
J Am Anim Hosp Assoc; 2021 Jan; 57(1):15-25. PubMed ID: 33260213
[TBL] [Abstract][Full Text] [Related]
5. Hepatocutaneous syndrome in Shih Tzus: 31 cases (1996-2014).
Hall-Fonte DL; Center SA; McDonough SP; Peters-Kennedy J; Trotter TS; Lucy JM; Berger E; Byers C; Cummings CG; Burke E; Stegemen J; Pintar J; Kantrowitz L; Sharpe K; Weinkle T
J Am Vet Med Assoc; 2016 Apr; 248(7):802-13. PubMed ID: 27003022
[TBL] [Abstract][Full Text] [Related]
6. Hepatic ultrasonography and pathological findings in dogs with hepatocutaneous syndrome: new concepts.
Jacobson LS; Kirberger RM; Nesbit JW
J Vet Intern Med; 1995; 9(6):399-404. PubMed ID: 8558487
[TBL] [Abstract][Full Text] [Related]
7. Successful Long-Term Management of Canine Superficial Necrolytic Dermatitis With Amino Acid Infusions and Nutritionally Balanced Home-Made Diet Modification.
Jaffey JA; Backus RC; Sprinkle M; Ruggiero C; Ferguson SH; Shumway K
Front Vet Sci; 2020; 7():28. PubMed ID: 32083106
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Management with Adipose Tissue-Derived Mesenchymal Stem Cells and Conventional Treatment in a Dog with Hepatocutaneous Syndrome.
Nam A; Han SM; Go DM; Kim DY; Seo KW; Youn HY
J Vet Intern Med; 2017 Sep; 31(5):1514-1519. PubMed ID: 28782844
[TBL] [Abstract][Full Text] [Related]
9. Pathology in practice. Superficial necrolytic dermatitis and nodular hepatopathy (lesions consistent with hepatocutaneous syndrome).
Brenseke BM; Belz KM; Saunders GK
J Am Vet Med Assoc; 2011 Feb; 238(4):445-7. PubMed ID: 21320012
[No Abstract] [Full Text] [Related]
10. Characterization of aminoaciduria and hypoaminoacidemia in dogs with hepatocutaneous syndrome.
Loftus JP; Center SA; Lucy JM; Stanton JA; McDonough SP; Peters-Kennedy J; Arceneaux KA; Bechtold MA; Bennett CL; Bradbury CA; Cline MG; Hall-Fonte DL; Hammer-Landrum JF; Huntingford JL; Marshall J; Sharpe KS; Redin JL; Selva ST; Lucia TA
Am J Vet Res; 2017 Jun; 78(6):735-744. PubMed ID: 28541155
[TBL] [Abstract][Full Text] [Related]
11. Short-term parenteral infusions with high-osmolality amino acid solutions can be safely administered through peripheral catheters in dogs treated for hypoaminoacidemia-related conditions.
Arsenault AC; Loftus JP; Rishniw M
J Am Vet Med Assoc; 2024 Feb; ():1-6. PubMed ID: 38354472
[TBL] [Abstract][Full Text] [Related]
12. Plasma amino acid concentrations in 36 dogs with histologically confirmed superficial necrolytic dermatitis.
Outerbridge CA; Marks SL; Rogers QR
Vet Dermatol; 2002 Aug; 13(4):177-86. PubMed ID: 12174180
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of glucagon and glucagon-like peptide-1 are reduced in dogs with aminoaciduric canine hypoaminoacidemic hepatopathy syndrome versus healthy dogs: a preliminary study.
Holm SM; Peng SA; Holter MM; Cummings BP; Loftus JP
Am J Vet Res; 2023 Apr; 84(4):. PubMed ID: 36773290
[TBL] [Abstract][Full Text] [Related]
14. Metabolic epidermal necrosis-hepatocutaneous syndrome.
Byrne KP
Vet Clin North Am Small Anim Pract; 1999 Nov; 29(6):1337-55. PubMed ID: 10563004
[TBL] [Abstract][Full Text] [Related]
15. Superficial necrolytic dermatitis (necrolytic migratory erythema) in dogs.
Gross TL; Song MD; Havel PJ; Ihrke PJ
Vet Pathol; 1993 Jan; 30(1):75-81. PubMed ID: 8442331
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-producing pancreatic endocrine tumors in two dogs with superficial necrolytic dermatitis.
Gross TL; O'Brien TD; Davies AP; Long RE
J Am Vet Med Assoc; 1990 Dec; 197(12):1619-22. PubMed ID: 2276959
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological, ultrasonographic, and histopathological findings of superficial necrolytic dermatitis with hepatopathy in a cat.
Kimmel SE; Christiansen W; Byrne KP
J Am Anim Hosp Assoc; 2003; 39(1):23-7. PubMed ID: 12549610
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocutaneous syndrome].
van der Luer R; van den Ingh T; van Hoe N; Neuteboom J
Tijdschr Diergeneeskd; 2007 Dec; 132(23):920-2. PubMed ID: 18085175
[No Abstract] [Full Text] [Related]
19. Nutraceuticals for canine liver disease: assessing the evidence.
Vandeweerd JM; Cambier C; Gustin P
Vet Clin North Am Small Anim Pract; 2013 Sep; 43(5):1171-9. PubMed ID: 23890245
[TBL] [Abstract][Full Text] [Related]
20. Superficial necrolytic dermatitis in 11 dogs with a history of phenobarbital administration (1995-2002).
March PA; Hillier A; Weisbrode SE; Mattoon JS; Johnson SE; DiBartola SP; Brofman PJ
J Vet Intern Med; 2004; 18(1):65-74. PubMed ID: 14765734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
